Karessa develops fast-acting drugs for erectile dysfunction

Karessa is a Swedish pharmaceutical company that aims to revolutionise the market for medicinal products treating erectile dysfunction. Through innovation and patented drug delivery platform, we want to help men to regain their sexual potency – without the need to plan far in advance.

Our medicinal product will not be taken in tablet form, but will instead be delivered directly into the bloodstream via a film that is applied discreetly to the oral mucosa. The main advantages for the patient include a faster and more reliable effect compared with today's preparations.

Our business model is based on combining proven, effective and approved substances with our own patented drug delivery platform. Through this combination, we are generating significant benefits, both for the patient and for Karessa itself. For Karessa as a company, the combination means a shorter time to market, lower development costs and reduced risk compared with traditional drug development.

The plattform

Plattform presentation


Analysguiden May, 2017
Watch video (In Swedish)


Press releases



Status project K-03

Last patient is dosed in Karessa's clinical study (Phase I) with K-03 Vardenafil buccal film. Final results from the study will be reported in the beginning of April 2018.

Read more about K-03 and our other projects here

Karessa in Life Science Sweden

Karessa and CEO Michael Brobjer are mentioned in an article about this year's Pharma Outsourcing.

Read the article (in Swedish) ”Utvecklare möttes på Pharma Outsourcing” 

Karessa's work is mentioned

New article about Karessa's unique platform and development work with drugs to treat erectile dysfunction.

Read the article (in Swedish) ”Utvecklar läkemedel mot impotens” 
(December 2017)

undefined40 per cent of all 40-year-old men are affected

40 per cent of all 40-year-old men suffer from erectile dysfunction, i.e. the inability to achieve and maintain an erection sufficient to enable successful intercourse. The reasons may be physical, mental, or a combination of both. The biggest underlying factors include age, other medications and lifestyle.

Read more about the market for medicinal products treating erectile dysfunction here.